vimarsana.com

Latest Breaking News On - Dani kass - Page 13 : vimarsana.com

Where Key Patent Policy Issues Stand In 2023

U.S. Patent and Trademark Office Director Kathi Vidal spent her first year in office rolling out initiatives on everything from patent eligibility to discretionary denials of patent challenges, efforts that attorneys still plan to watch as the new year unfolds. Here's a look at the policies that Vidal and others have set in motion and could advance in 2023.

Fed Circ Won t Revive Genentech Lung Disease Patents

A Delaware federal judge rightly invalidated claims in a Roche unit's patents for a lung disease drug it paid $8 billion to acquire and properly held that a Novartis unit's generic version doesn't infringe, the Federal Circuit said Thursday.

4 Updates From IP Leadership You Should Know About

The U.S. Patent and Trademark Office and the Library of Congress have named new key leaders over the last week, as well as issued updates on a study of nonfungible tokens and practicing at the Copyright Claims Board. Here's what you need to know.

Richards Layton Atty Tests Del Judge s Patience In IP Row

A Richards Layton & Finger PA director has taken responsibility for what U.S. District Judge Richard G. Andrews called "as frivolous a motion to seal as I have seen," after the attorney for YouTube tried to redact information easily found on LinkedIn as if it came from "a confidential source for the CIA."

The Biggest Patent Rulings Of 2022

The Federal Circuit found an artificial intelligence system can't be an inventor, while the new U.S. Patent and Trademark Office director sanctioned a patent challenger for misconduct and a Western District of Texas order loosened Judge Alan Albright's grip on patent cases in Waco. Here are Law360's picks for the top patent rulings of 2022.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.